Sanara MedTech Inc. — Director's Dealing 2014

Feb 14, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (wndm)
CIK: 0000714256
Period of Report: 2013-12-31

Reporting Person: Rubinfeld Philip J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-19	Series C Preferred Stock	$	P	1723	Acquired		Common Stock (1723000)	Direct

Footnotes

F1: Each share of Series C Preferred Stock is convertible into 1,000 shares of the issuer's common stock, subject to the effectiveness of an increase in the authorized number of shares of common stock from 100,000,000 to 250,000,000.